The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $21,899,809 in first-year total cost, median $2,822,756.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-M (O4)]8
Most frequent institutions
- HENNEPIN HEALTHCARE RESEARCH INSTITUTE1
- MASSACHUSETTS GENERAL HOSPITAL1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- UNIVERSITY OF ILLINOIS AT CHICAGO1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Pain, Opioids, and ESRD risk reduction with Mindfulness and Buprenorphine (POEM-B): A 3-arm multi-site randomized trial in hemodialysis patients1U01DK123814-01 | CHARYTAN, DAVID MLEE, JOSHUA DSHALLCROSS, AMANDA J | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $2,883,251 | ZDK1 |
| 2019 | Vanderbilt-West Virginia (VWV) Collaborative: A HOPE Consortium Clinical Center1U01DK123821-01 | CAVANAUGH, KERRI | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $2,863,288 | ZDK1 |
| 2019 | Pain Reduction and Opioid MedIcation Safety in ESRD (PROMISE) study1U01DK123812-01 | JHAMB, MANISHALIEBSCHUTZ, JANE MSTEEL, JENNIFER L.YABES, JONATHAN G | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,847,465 | ZDK1 |
| 2019 | University of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical Center1U01DK123787-01 | DOORENBOS, ARDITH ZFISCHER, MICHAEL J. | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $2,845,360 | ZDK1 |
| 2019 | Randomized ESRD Trial COmparing CBT alone VERsus with buprenorphine (RECOVER)1U01DK123786-01 | CUKOR, DANIELMEHROTRA, RAJNISHUNRUH, MARK LYNN | UNIVERSITY OF WASHINGTON, WA | $2,800,151 | ZDK1 |
| 2019 | The Hemodialysis Opioid Prescription Effort Consortium1U01DK123816-01 | BART, GAVINJOHANSEN, KIRSTEN L.KREBS, ERIN ELIZABETHLIU, JIANNONG | HENNEPIN HEALTHCARE RESEARCH INSTITUTE, MN | $2,647,931 | ZDK1 |
| 2019 | Video-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving Hemodialysis1U01DK123817-01 | BECKER, WILLIAM CCROWLEY, SUSAN TESSERMAN, DENISEHEAPY, ALICIA | YALE UNIVERSITY, CT | $2,601,322 | ZDK1 |
| 2019 | Reducing Chronic Pain and Opioid Use in Hemodialysis Patients1U01DK123818-01 | KALIM, SAHIRNIGWEKAR, SAGAR | MASSACHUSETTS GENERAL HOSPITAL, MA | $2,411,041 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.